Valeant To Participate At Goldman Sachs Third Annual Leveraged Finance Conference
Valeant To Participate At Goldman Sachs Third Annual Leveraged Finance Conference |
[03-May-2018] |
LAVAL, Quebec, May 3, 2018 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) ("Valeant") today announced that Paul S. Herendeen, executive vice president, Finance, and chief financial officer, is scheduled to participate at the Goldman Sachs Third Annual Leveraged Finance Conference in Rancho Palos Verdes, Calif. on Thursday, May 10, 2018 at 2:10 p.m. PDT (5:10 p.m. EDT). A live webcast and audio archive of the event will be available on the Investor Relations page of the Valeant web site at: http://ir.valeant.com/events-and-presentations/2018. About Valeant
View original content with multimedia:http://www.prnewswire.com/news-releases/valeant-to-participate-at-goldman-sachs-third-annual-leveraged-finance-conference-300638425.html SOURCE Valeant Pharmaceuticals International, Inc. | ||||||||||||
Company Codes: NYSE:VRX, Toronto:VRX |
© 2018 PR Newswire. All Rights Reserved.